MADRIGAL PHARMACEUTICALS, INC.
Total Trades
100
Buys
4
Sells
58
Largest Trade
N/A
Insiders
14
Institutional Funds
313
Inst. Value
$1M+
Activist Filings
38
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| BATE KENNETH | Director | EXERCISE | $1M+ | 20K | $66.26 | Feb 28, 2025 |
| BATE KENNETH | Director | SELL | $1M+ | 20K | $356.44 | Feb 28, 2025 |
| Huntsman Carole | Chief Commercial O… | SELL | $100K–$500K | 347 | $335.24 | Jan 27, 2025 |
| Sibold William John | President and CEO | SELL | $500K+ | 2K | $335.24 | Jan 27, 2025 |
| Taub Rebecca | Pres., R&D, and CMO | SELL | $100K–$500K | 648 | $335.24 | Jan 27, 2025 |
| Waltermire Robert E. | Senior VP | SELL | $15K–$50K | 103 | $335.24 | Jan 27, 2025 |
| Kelley Shannon T | General Counsel | SELL | $50K–$100K | 277 | $273.41 | Jan 18, 2025 |
| Waltermire Robert E. | Senior VP | SELL | $100K–$500K | 442 | $273.41 | Jan 18, 2025 |
| Taub Rebecca | Pres., R&D, and CMO | SELL | $100K–$500K | 2K | $273.41 | Jan 18, 2025 |
| CRAVES FRED B | Director | SELL | $1M+ | 3K | $350.30 | Nov 27, 2024 |
| Huntsman Carole | Chief Commercial O… | SELL | $100K–$500K | 688 | $316.92 | Nov 22, 2024 |
| Levy Richard S | Director | SELL | $1M+ | 5K | $350.00 | Nov 8, 2024 |
| Levy Richard S | Director | EXERCISE | $15K–$50K | 5K | $7.36 | Nov 8, 2024 |
| Levy Richard S | Director | SELL | $1M+ | 5K | $300.94 | Nov 6, 2024 |
| Levy Richard S | Director | EXERCISE | $15K–$50K | 5K | $7.36 | Nov 6, 2024 |
| Waltermire Robert E. | Senior VP | EXERCISE | $100K–$500K | 2K | $87.09 | Jun 19, 2024 |
| Waltermire Robert E. | Senior VP | SELL | $500K+ | 2K | $280.00 | Jun 19, 2024 |
| Waltermire Robert E. | Senior VP | EXERCISE | $100K–$500K | 2K | $87.92 | Jun 15, 2024 |
| Waltermire Robert E. | Senior VP | SELL | $500K+ | 2K | $285.00 | Jun 15, 2024 |
| Waltermire Robert E. | Senior VP | SELL | $100K–$500K | 1K | $231.34 | May 24, 2024 |
| Taub Rebecca | Pres., R&D, and CMO | EXERCISE | $15K–$50K | 3K | $9.45 | Apr 11, 2024 |
| Taub Rebecca | Pres., R&D, and CMO | SELL | $500K+ | 3K | $245.99 | Apr 11, 2024 |
| FRIEDMAN PAUL A | Director | EXERCISE | $100K–$500K | 26K | $9.45 | Apr 11, 2024 |
| FRIEDMAN PAUL A | Director | SELL | $1M+ | 26K | $246.19 | Apr 11, 2024 |
| Taub Rebecca | Pres., R&D, and CMO | EXERCISE | $500K+ | 74K | $9.45 | Apr 6, 2024 |
| Taub Rebecca | Pres., R&D, and CMO | SELL | $1M+ | 74K | $243.92 | Apr 6, 2024 |
| FRIEDMAN PAUL A | Director | SELL | $1M+ | 74K | $243.93 | Apr 6, 2024 |
| FRIEDMAN PAUL A | Director | EXERCISE | $500K+ | 74K | $9.45 | Apr 6, 2024 |
| Levy Richard S | Director | EXERCISE | $500K+ | 11K | $63.92 | Apr 4, 2024 |
| Levy Richard S | Director | SELL | $1M+ | 11K | $257.49 | Apr 4, 2024 |
| BATE KENNETH | Director | SELL | $1M+ | 32K | $252.85 | Apr 4, 2024 |
| BATE KENNETH | Director | EXERCISE | $1M+ | 32K | $74.22 | Apr 4, 2024 |
| Daly James M | Director | EXERCISE | $1M+ | 32K | $102.23 | Apr 4, 2024 |
| Daly James M | Director | SELL | $1M+ | 32K | $252.97 | Apr 4, 2024 |
| Lynch Brian Joseph | SVP and General Co… | SELL | $1M+ | 7K | $201.50 | Dec 1, 2023 |
| Lynch Brian Joseph | SVP and General Co… | EXERCISE | $500K+ | 7K | $73.75 | Dec 1, 2023 |
| BAKER BROS. ADVISORS LP | Director | BUY | $1M+ | 64K | $188.47 | Nov 21, 2023 |
| BAKER BROS. ADVISORS LP | Director | BUY | $1M+ | 67K | $178.11 | Nov 21, 2023 |
| BAKER BROS. ADVISORS LP | Director | BUY | $1M+ | 49K | $158.13 | Nov 15, 2023 |
| BAKER BROS. ADVISORS LP | Director | BUY | $1M+ | 107K | $146.99 | Nov 15, 2023 |
| Waltermire Robert E. | Senior VP | SELL | $1M+ | 10K | $273.24 | Mar 2, 2023 |
| Waltermire Robert E. | Senior VP | EXERCISE | $500K+ | 10K | $87.92 | Mar 2, 2023 |
| Levy Richard S | Director | SELL | $1M+ | 22K | $293.15 | Jan 20, 2023 |
| Levy Richard S | Director | EXERCISE | $1M+ | 22K | $103.02 | Jan 20, 2023 |
| Lynch Brian Joseph | SVP and General Co… | EXERCISE | $1M+ | 13K | $91.79 | Jan 6, 2023 |
| Lynch Brian Joseph | SVP and General Co… | SELL | $1M+ | 13K | $282.92 | Jan 6, 2023 |
| Lynch Brian Joseph | SVP and General Co… | SELL | $1M+ | 7K | $274.18 | Dec 29, 2022 |
| Lynch Brian Joseph | SVP and General Co… | EXERCISE | $500K+ | 7K | $91.79 | Dec 29, 2022 |
| Sukhija Remy | Chief Commercial O… | EXERCISE | $1M+ | 30K | $60.26 | Dec 29, 2022 |
| Sukhija Remy | Chief Commercial O… | SELL | $1M+ | 30K | $274.14 | Dec 29, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 313 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PAULSON & CO. INC. | 1.7M | $1M+ | SH |
| STATE STREET CORP | 583K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 392K | $1M+ | SH |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 354K | $1M+ | SH |
| LORD, ABBETT & CO. LLC | 241K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 219K | $1M+ | SH |
| NORGES BANK | 196K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 185K | $1M+ | SH |
| Pictet Asset Management Holding SA | 182K | $1M+ | SH |
| Erste Asset Management GmbH | 141K | $1M+ | SH |
| Point72 Asset Management, L.P. | 126K | $1M+ | SH |
| MPM BioImpact LLC | 97K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 84K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 83K | $1M+ | SH |
| NEW YORK STATE COMMON RETIREMENT FUND | 76K | $1M+ | SH |
| Squarepoint Ops LLC | 75K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 74K | $1M+ | SH |
| UBS Group AG | 68K | $1M+ | SH |
| First Light Asset Management, LLC | 67K | $1M+ | SH |
| Candriam S.C.A. | 64K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 17, 2026
7.5%
1.7M shares
SC 13G/A · Feb 17, 2026
7.0%
1.6M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13D/A · Dec 12, 2025
7.8%
1.8M shares
SC 13G/A · Nov 14, 2025
8.3%
1.8M shares
SC 13G/A · Aug 14, 2025
9.9%
2.2M shares
SC 13G/A · May 14, 2025
10.0%
2.2M shares
SC 13G/A · Feb 14, 2025
10.1%
2.2M shares
SC 13G/A · Nov 14, 2024
9.4%
2.0M shares
SC 13G · Nov 14, 2024
9.2%
2.0M shares
SC 13D/A · Mar 25, 2024
10.0%
2.1M shares
SC 13G/A · Feb 14, 2024
5.6%
1.1M shares
SC 13G/A · Feb 14, 2024
0.3%
50K shares
SC 13G/A · Feb 14, 2024
9.9%
2.3M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Feb 13, 2024
14.7%
2.9M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.0%
1.6M shares
SC 13G/A · Jan 29, 2024
6.1%
1.2M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G/A · Jan 22, 2024
3.5%
0 shares
SC 13D/A · Dec 13, 2023
2.9%
568K shares
SC 13D/A · Nov 21, 2023
10.0%
2.0M shares
SC 13G · Nov 13, 2023
5.1%
1.0M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G/A · Oct 10, 2023
15.4%
3.0M shares
SC 13D/A · Oct 5, 2023
10.0%
2.0M shares
Janus Henderson Group plc EIN #00-0000000
SC 13G · Sep 8, 2023
10.3%
1.9M shares
SC 13D/A · Aug 8, 2023
8.4%
1.5M shares
SC 13D · Jun 16, 2023
8.4%
1.5M shares
SC 13G/A · Feb 14, 2023
9.0%
1.5M shares
SC 13G/A · Feb 14, 2023
1.2%
208K shares
SC 13G/A · Feb 14, 2023
9.7%
1.7M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Feb 2, 2023
7.4%
0 shares
SC 13G/A · Feb 1, 2023
5.8%
987K shares
SC 13G · May 19, 2022
5.4%
918K shares
SC 13G · Feb 14, 2022
6.6%
1.1M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
SC 13G/A · Feb 11, 2022
8.3%
1.4M shares